Ehsaan Akhtar, MD
Gastroenterology · Kirkland
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 3
- Since medical school
- 13 years
- University of California, Davis School of Medicine, 2013
Offices
3 locations · King County Public Hospital District No 2 · Community Foundation Medical Group
Hospitals listed: Evergreenhealth Medical Center · Evergreenhealth Monroe. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Akhtar’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A133960 · Current
Licensed to practise in California · since 2014 · expires 2028-11-30 · University of California, Davis School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
State licence records
1 licence
- Washington MD.MD.61519396Physician And Surgeon License · since 2024 · expires 2028-11-25Matched by name, not licence number; check the name before relying on it.ActiveNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Gastroenterology
- American Board of Internal Medicine - Internal Medicine
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Evergreenhealth Medical CenterKirkland, WAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of EvergreenHealth, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.335, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Evergreenhealth MonroeMonroe, WAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency departmentPart of EvergreenHealth, which runs 2 hospitalsPatients rate it 2 of 5 · 66% would definitely recommend itOverall rating: 3 of 5 starsNo measure marked better or worse than the national rate
See every measure and the patient survey for Evergreenhealth Medical Center
Behind the star rating — Deaths: 3 better, 4 the same, 0 worse of 7 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 1 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.335 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.1 (0.11 to 2.09) · 1,003 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.75 (0.44 to 1.07) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 158.5 (106.49 to 210.51) · 62 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.5 · 80 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 138 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.2 · 650 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.6 · 512 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.7 · 419 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.6 · 3,509 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 6,473 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.35 (0.16 to 0.54) · 6,368 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.57 (0.58 to 4.56) · 1,401 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.51 (0 to 3.16) · 559 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.37 (0.83 to 3.91) · 1,295 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 5.67 (0 to 12.54) · 573 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.57 (0.84 to 8.31) · 535 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.14 to 3.07) · 268 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.33 (0 to 0.99) · 5,577 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.6 · 202 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.642 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.708 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.331 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.2 · 197 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.9 · 942 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -28.3 · 136 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -0.2 · 719 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 26.7 · 521 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.9 · 708 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.8 (3.1 to 7.7) · 57 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.3 (6.3 to 13.8) · 57 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 200 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.7 · 137 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14 (10.5 to 18.7) · 566 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.9 to 1.4) · 1,099 cases | No different | Jan 2024 – Dec 2024 |
What patients said (481 patients answered, 19% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 72% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 88% |
| Patients who gave a rating of "9" or "10" (high) | 77% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 57% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for Evergreenhealth Monroe
Behind the star rating — Deaths: 0 better, 3 the same, 0 worse of 3 measures. Safety: 0 better, 1 the same, 0 worse of 1 measures. Readmissions: 0 better, 5 the same, 0 worse of 5 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.04 (0 to 2.13) · 35 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.96 (0.46 to 1.46) | No different | Jul 2022 – Jun 2024 |
| Death rate for heart failure patientsComplications and deaths | 11.1 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.2 · 57 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.9 · 28 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.5 · 429 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.21 (0 to 0.44) · 469 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.05 to 0.48) · 443 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.42 (0.81 to 6.04) · 55 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.31 (0.59 to 4.04) · 52 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.74 (0.22 to 3.26) · 28 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.55 (0 to 1.82) · 331 cases | No different | Jul 2022 – Jun 2024 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.6 · 89 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -27 · 47 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -33.6 · 52 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.4 · 97 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.6 · 26 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.1 · 42 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (9.5 to 17.7) · 70 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.5) · 43 cases | No different | Jan 2024 – Dec 2024 |
What patients said (225 patients answered, 24% of those asked)
| Cleanliness | 4 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 73% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 65% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 67% |
| Nurses "always" listened carefully | 68% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 41% |
| "YES", patients would definitely recommend the hospital | 66% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 84% |
Original Medicare doctor bills
$87,956
Medicare paid this office $87,956 for 421 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 113 | $16,654 | $92 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 62 | $9,608 | $155 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 108 | $9,403 | $85 |
| Biopsy of large bowel using a flexible endoscope | 70 | $6,019 | $86 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 48 | $5,200 | $104 |
See all 18 services
| Return visit (30+ min) | 113 | $16,654 | $92 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 62 | $9,608 | $155 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 108 | $9,403 | $85 |
| Biopsy of large bowel using a flexible endoscope | 70 | $6,019 | $86 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 48 | $5,200 | $104 |
| Diagnostic exam of large bowel using a flexible endoscope | 35 | $4,569 | $131 |
| Removal of large bowel tissue using a flexible endoscope | 15 | $3,962 | $264 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 18 | $3,221 | $179 |
| Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope through mouth | 25 | $3,052 | $117 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 31 | $2,771 | $89 |
| Short return visit (20+ min) | 36 | $2,128 | $55 |
| Removal of stone or debris from bile or pancreatic duct using a flexible endoscope | 11 | $1,665 | $128 |
| New patient visit (45+ min) | 14 | $1,635 | $117 |
| Return visit (30+ min) | 15 | $1,477 | $82 |
| New patient visit (45+ min) | 11 | $1,236 | $112 |
| New patient visit (30+ min) | 15 | $749 | $50 |
| Dilation of esophagus | 17 | $595 | $31 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 125 | $530 | $4 |
Procedures Medicare counted
| Colonoscopy | 46 | More than 62% of doctors who do this |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 176 | More than 88% of doctors who do this |
Procedures year by year
| Procedure | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 80 | 189 | 205 | 216 | 111 |
| Biopsy of large bowel using a flexible endoscope | 35 | 99 | 92 | 92 | 70 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 42 | 71 | 76 | 78 | 62 |
| Diagnostic exam of large bowel using a flexible endoscope | 36 | 64 | 82 | 49 | 35 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 14 | 66 | 69 | 47 | 31 |
| Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope through mouth | 22 | 30 | 27 | 22 | 26 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
421 Original Medicare patients in 2024. Average age 72 · Under 65 13% · 85 and older 9% · Women 55% · Also on Medicaid 53% · Health risk score 1.93. Above the middle of the specialty; the typical gastroenterology clinician is at 1.42.
Conditions among them: High blood pressure 75% · Diabetes 49% · Coronary heart disease 35% · Chronic kidney disease 35% · Depression 27% · Heart failure 25% · COPD 25% · Cancer 19% · Atrial fibrillation 18% · Dementia 11% · Stroke 10%.
The office billed $661,427, Medicare allowed $116,765 and paid $87,956; for 964 services of 50 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 421 | 964 | 72 | 1.93 | $661,427 | $87,956 |
| 2023 | 609 | 1,313 | 72 | 1.80 | $1,019,504 | $132,764 |
| 2022 | 668 | 1,411 | 72 | 1.67 | $644,195 | $162,308 |
| 2021 | 652 | 1,440 | 72 | 1.87 | $570,975 | $151,968 |
| 2020 | 450 | 878 | 71 | 1.64 | $290,637 | $89,936 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 19 services
| Return visit (30+ min) | 163 | $26,413 | $101 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 210 | $18,664 | $86 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 76 | $14,775 | $189 |
| Biopsy of large bowel using a flexible endoscope | 90 | $9,098 | $99 |
| Diagnostic exam of large bowel using a flexible endoscope | 49 | $5,672 | $116 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 47 | $4,842 | $101 |
| Insertion of stent into pancreatic or bile duct using a flexible endoscope | 12 | $4,813 | $370 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 44 | $4,350 | $93 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 24 | $4,264 | $178 |
| Short return visit (20+ min) | 51 | $4,212 | $69 |
| New patient visit (45+ min) | 29 | $3,856 | $133 |
| New patient visit (30+ min) | 36 | $2,975 | $83 |
| Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope through mouth | 22 | $2,578 | $117 |
| Removal of stone or debris from bile or pancreatic duct using a flexible endoscope | 15 | $2,147 | $119 |
| Ultrasound guided needle aspiration or biopsy of esophagus using a flexible endoscope | 11 | $1,647 | $150 |
| Dilation of esophagus | 30 | $1,151 | $32 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $708 | $64 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 117 | $503 | $4 |
| Review by radiologist of image from tube placement into bile duct using an endoscope | 11 | $246 | $19 |
2022: 18 services
| Return visit (30+ min) | 169 | $28,373 | $99 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 199 | $17,192 | $84 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 75 | $13,594 | $179 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 78 | $13,211 | $157 |
| Diagnostic exam of large bowel using a flexible endoscope | 82 | $11,552 | $141 |
| Biopsy of large bowel using a flexible endoscope | 92 | $9,803 | $107 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 72 | $7,904 | $107 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 68 | $6,242 | $90 |
| Short return visit (20+ min) | 69 | $5,271 | $64 |
| New patient visit (30+ min) | 56 | $4,621 | $83 |
| Removal of large bowel tissue using a flexible endoscope | 16 | $4,283 | $268 |
| Ultrasound guided needle aspiration or biopsy of esophagus using a flexible endoscope | 19 | $3,757 | $157 |
| Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope through mouth | 27 | $3,676 | $136 |
| New patient visit (45+ min) | 27 | $3,561 | $132 |
| Insertion of guide wire with dilation of esophagus using a flexible endoscope | 22 | $2,678 | $122 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 11 | $2,049 | $186 |
| Insertion of stomach tube using a flexible endoscope | 12 | $1,925 | $160 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 36 | $174 | $4 |
2021: 17 services
| Return visit (30+ min) | 172 | $22,753 | $87 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 185 | $14,587 | $77 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 86 | $13,924 | $153 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 69 | $13,693 | $193 |
| Short return visit (20+ min) | 148 | $13,345 | $61 |
| Biopsy of large bowel using a flexible endoscope | 97 | $12,247 | $124 |
| Diagnostic exam of large bowel using a flexible endoscope | 63 | $9,064 | $142 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 62 | $5,938 | $90 |
| Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope through mouth | 30 | $4,604 | $153 |
| New patient visit (45+ min) | 32 | $3,654 | $114 |
| New patient visit (30+ min) | 46 | $3,368 | $73 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 29 | $3,202 | $107 |
| Insertion of stomach tube using a flexible endoscope | 17 | $3,101 | $155 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 16 | $2,943 | $184 |
| Insertion of guide wire with dilation of esophagus using a flexible endoscope | 19 | $2,210 | $116 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 26 | $1,871 | $55 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 26 | $119 | $4 |
2020: 14 services
| Return visit (30+ min) | 152 | $15,350 | $71 |
| New patient visit (45+ min) | 81 | $9,213 | $114 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 42 | $8,856 | $211 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 80 | $6,743 | $84 |
| Short return visit (20+ min) | 119 | $6,538 | $47 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 34 | $5,808 | $161 |
| Biopsy of large bowel using a flexible endoscope | 35 | $5,737 | $164 |
| Diagnostic exam of large bowel using a flexible endoscope | 36 | $5,585 | $155 |
| New patient visit (30+ min) | 70 | $4,572 | $65 |
| Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope through mouth | 21 | $3,370 | $153 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 13 | $2,322 | $179 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 13 | $1,286 | $92 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $1,198 | $60 |
| Short return visit | 11 | $305 | $25 |
Medicaid work
$3,124 in 2024
Medicaid paid $3,124 for 734 billed services this clinician did in 2024, up to 31 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Upper gastrointestinal endoscopy with biopsy | 189 | $1,510 |
| COLONOSCOPY W/LESION REMOVAL | 25 | $342 |
| Service | 65 | $327 |
| DIAGNOSTIC COLONOSCOPY | 27 | $302 |
| Return visit (30+ min) | 84 | $211 |
| TISSUE EXAM BY PATHOLOGIST | 15 | $192 |
| COLONOSCOPY AND BIOPSY | 14 | $86 |
| Service | 65 | $59 |
| Infusion, normal saline solution , 1000 cc | 68 | $41 |
| Injection, propofol, 10 mg | 72 | $32 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | 41 | $22 |
| Service | 17 | $0 |
| 2024 | 734 | 13 | 31 | $3,124 |
| 2023 | 504 | 11 | 21 | $3,004 |
| 2022 | 503 | 12 | 30 | $1,719 |
| 2021 | 249 | 10 | 16 | $86 |
See the largest Medicaid services in earlier years
2023
| Upper gastrointestinal endoscopy with biopsy | 195 | $1,331 |
| IP/OBS CONSLTJ NEW/EST PT MOD MDM 60 MINUTES | 34 | $671 |
| Diagnostic upper gastrointestinal endoscopy | 14 | $596 |
| Return visit (30+ min) | 131 | $304 |
| Injection, propofol, 10 mg | 53 | $59 |
| COLONOSCOPY AND BIOPSY | 12 | $40 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | 15 | $2 |
| Service | 12 | $0 |
| Service | 13 | $0 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older | 12 | $0 |
| Infusion, normal saline solution , 1000 cc | 13 | $0 |
2022
| Upper gastrointestinal endoscopy with biopsy | 188 | $1,037 |
| Return visit (30+ min) | 60 | $325 |
| Diagnostic upper gastrointestinal endoscopy | 15 | $202 |
| IP/OBS CONSLTJ NEW/EST PT MOD MDM 60 MINUTES | 16 | $117 |
| Injection, propofol, 10 mg | 27 | $38 |
| Service | 39 | $0 |
| Service | 39 | $0 |
| Service | 39 | $0 |
| COLONOSCOPY AND BIOPSY | 12 | $0 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular | 20 | $0 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older | 32 | $0 |
| Short return visit (20+ min) | 16 | $0 |
2021
| Injection, propofol, 10 mg | 58 | $36 |
| Basic metabolic panel (Calcium, ionized) This panel must include the following: Calcium, ionized (82330) Carbon dioxide (bicarbonate) (82374) Chloride (82435) Creatinine (82565) Glucose (82947) Potassium (84132) Sodium (84295) Urea Nitrogen (BUN) (84520) | 27 | $20 |
| TISSUE EXAM BY PATHOLOGIST | 24 | $18 |
| BLOOD COUNT HEMATOCRIT | 27 | $6 |
| HEMOGLOBIN | 27 | $6 |
| Service | 24 | $0 |
| Service | 12 | $0 |
| Upper gastrointestinal endoscopy with biopsy | 25 | $0 |
| Short return visit (20+ min) | 13 | $0 |
| Return visit (30+ min) | 12 | $0 |
Drugs they prescribed that Part D paid
$103,269
Pharmacies billed $103,269 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 283) in 2024. At or below the middle of the specialty; the typical gastroenterology clinician is at 0%.
230 generic and 53 brand-name prescriptions · $103,269 in drug cost · 17 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Linzess | 25 | $21,051 | $842 |
| Cholestyramine | 14 | $1,278 | $91 |
| Gavilyte-C | 34 | $556 | $16 |
| Dicyclomine | 52 | $500 | $10 |
| Famotidine | 18 | $300 | $17 |
See all 7 drugs
| Linzess | 25 | $21,051 | $842 |
| Cholestyramine | 14 | $1,278 | $91 |
| Gavilyte-C | 34 | $556 | $16 |
| Dicyclomine | 52 | $500 | $10 |
| Famotidine | 18 | $300 | $17 |
| Pantoprazole | 19 | $191 | $10 |
| Omeprazole | 22 | $182 | $8 |
Year by year
| 2024 | 283 | 113 | 0% (0) | 19% | $103,269 |
| 2023 | 320 | 133 | 0% (0) | 12% | $79,235 |
| 2022 | 427 | 193 | None | 23% | $153,525 |
| 2021 | 427 | 201 | None | 19% | $43,926 |
| 2020 | 212 | 126 | None | 15% | $16,070 |
| 2019 | 33 | 16 | 0% (0) | 39% | $13,370 |
| 2018 | 30 | 17 | 0% (0) | None | $3,027 |
| 2017 | 44 | 26 | None | None | $3,088 |
| 2016 | 107 | 31 | None | None | $10,867 |
| 2015 | 27 | None | None | None | $1,262 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 9 drugs
| Linzess | 18 | $15,590 | $866 |
| Budesonide Ec | 11 | $4,864 | $442 |
| Famotidine | 46 | $1,020 | $22 |
| Colestipol | 15 | $802 | $53 |
| Gavilyte-C | 41 | $689 | $17 |
| Dicyclomine | 31 | $574 | $19 |
| Baclofen | 11 | $540 | $49 |
| Pantoprazole | 27 | $505 | $19 |
| Omeprazole | 22 | $338 | $15 |
2022: 11 drugs
| Linzess | 16 | $10,919 | $682 |
| Dexilant | 15 | $6,349 | $423 |
| Colestipol | 15 | $1,225 | $82 |
| Famotidine | 53 | $627 | $12 |
| Peg 3350-Electrolyte | 30 | $610 | $20 |
| Omeprazole | 48 | $440 | $9 |
| Gavilyte-C | 18 | $298 | $17 |
| Dicyclomine | 24 | $286 | $12 |
| Pantoprazole | 37 | $262 | $7 |
| Peg-3350 and Electrolytes | 15 | $196 | $13 |
| Gavilyte-G | 15 | $196 | $13 |
2021: 11 drugs
| Dexilant | 14 | $5,856 | $418 |
| Suprep | 24 | $2,621 | $109 |
| Budesonide Ec | 12 | $1,613 | $134 |
| Cholestyramine | 14 | $1,530 | $109 |
| Pantoprazole | 42 | $765 | $18 |
| Omeprazole | 76 | $726 | $10 |
| Famotidine | 49 | $483 | $10 |
| Dicyclomine | 31 | $346 | $11 |
| Gavilyte-C | 21 | $274 | $13 |
| Peg-3350 and Electrolytes | 16 | $192 | $12 |
| Gavilyte-G | 16 | $154 | $10 |
2020: 6 drugs
| Suprep | 13 | $1,367 | $105 |
| Dicyclomine | 34 | $524 | $15 |
| Omeprazole | 31 | $371 | $12 |
| Pantoprazole | 29 | $251 | $9 |
| Gavilyte-G | 11 | $154 | $14 |
| Famotidine | 13 | $97 | $7 |
Money from drug and device companies
$871 in 2025
| 2025 | 3 | 6 | None | $871 |
| 2024 | 17 | 67 | None | $1,836 |
| 2023 | 11 | 129 | None | $1,882 |
| 2022 | 12 | 105 | None | $1,626 |
| 2021 | 10 | 76 | None | $1,219 |
| 2020 | 6 | 13 | None | $268 |
| 2019 | 3 | 10 | None | $315 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Steris | Trufreeze | $551 | 3 payments
|
| Olympus Corporation of the Americas | Single Use Electrosurgical Knife Kd-655 | $297 | 2 payments
|
| Intercept Pharmaceuticals | Ocaliva | $23 | 1 payment
|
See all 6 published payments
| Olympus Corporation of the Americas | Travel · 2025-12-16 | Single Use Electrosurgical Knife Kd-655 | $262 |
| Olympus Corporation of the Americas | Travel · 2025-12-16 | Single Use Electrosurgical Knife Kd-655 | $35 |
| Steris | Travel · 2025-12-05 | Trufreeze | $437 |
| Steris | Meals · 2025-12-04 | Trufreeze | $63 |
| Steris | Meals · 2025-12-04 | Trufreeze | $51 |
| Intercept Pharmaceuticals | Meals · 2025-01-14 | Ocaliva | $23 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $1,836
| Boston Scientific | None | $745 | 4 payments
|
| Abbvie | Skyrizi | $279 | 18 payments
|
| Janssen Biotech | Stelara | $201 | 12 payments
|
| Aimmune Therapeutics | Vowst | $137 | 12 payments
|
| Olympus America | Visiglide | $80 | 2 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $77 | 4 payments
|
| Pfizer | Xeljanz | $77 | 4 payments
|
| Intercept Pharmaceuticals | Ocaliva | $41 | 2 payments
|
| Olympus Corporation of the Americas | Single Use Electrosurgical Knife Kd-655 | $36 | 1 payment
|
| Fresenius Kabi USA | Idacio | $29 | 1 payment
|
| QOL Medical | Sucraid | $28 | 1 payment
|
| Lilly USA | Omvoh | $27 | 1 payment
|
| Madrigal Pharmaceuticals | Resmetirom | $23 | 1 payment
|
| Daiichi Sankyo | Injectafer | $18 | 1 payment
|
| Celgene | Zeposia | $14 | 1 payment
|
| Regeneron Healthcare Solutions | Dupixent | $13 | 1 payment
|
| Micro-tech Endoscopy USA | Eyemax | $12 | 1 payment
|
2023: $1,882
| AbbVie | Rinvoq | $511 | 33 payments
|
| Celgene | Zeposia | $421 | 30 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $320 | 24 payments
|
| Janssen Biotech | Stelara | $240 | 18 payments
|
| Ardelyx | Ibsrela | $150 | 11 payments
|
| Pfizer | Xeljanz | $83 | 4 payments
|
| Janssen Pharmaceuticals | Xarelto | $51 | 3 payments
|
| Takeda Pharmaceuticals U.S.A. | Entyvio | $39 | 2 payments
|
| Nestle Healthcare Nutrition | Zenpep | $27 | 2 payments
|
| Boehringer Ingelheim Pharmaceuticals | Cyltezo | $23 | 1 payment
|
| Intercept Pharmaceuticals | Ocaliva | $20 | 1 payment
|
2022: $1,626
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $467 | 23 payments
|
| Abbvie | Skyrizi | $436 | 38 payments
|
| Celgene | Zeposia | $240 | 20 payments
|
| Janssen Biotech | Stelara | $143 | 11 payments
|
| Regeneron Pharmaceuticals | None | $107 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Entyvio | $64 | 3 payments
|
| Ardelyx | Ibsrela | $41 | 2 payments
|
| Janssen Pharmaceuticals | Xarelto | $36 | 2 payments
|
| Intercept Pharmaceuticals | Ocaliva | $31 | 2 payments
|
| Genzyme | Dupixent | $25 | 1 payment
|
| Merck Sharp & Dohme | Dificid | $23 | 1 payment
|
| RedHill Biopharma | Movantik | $12 | 1 payment
|
2021: $1,219
| AbbVie | Humira | $532 | 39 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $228 | 16 payments
|
| Nestle HealthCare Nutrition | Zenpep | $201 | 12 payments
|
| E.R. Squibb & Sons L.L.C. | Zeposia | $121 | 1 payment
|
| Gilead Sciences | None | $49 | 3 payments
|
| RedHill Biopharma | Movantik | $20 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $20 | 1 payment
|
| Celgene | Zeposia | $18 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Entyvio | $15 | 1 payment
|
| Braintree Laboratories | Sutab | $13 | 1 payment
|
2020: $268
| AbbVie | Humira | $112 | 6 payments
|
| Alfasigma USA | Zelnorm | $44 | 2 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Relistor | $40 | 2 payments
|
| Micro-tech Endoscopy USA | Insight | $38 | 1 payment
|
| RedHill Biopharma | Movantik | $21 | 1 payment
|
| Daiichi Sankyo | Injectafer | $14 | 1 payment
|
2019: $315
| Boston Scientific | Spyglass | $203 | 3 payments
|
| Ferring Pharmaceuticals | Clenpiq | $57 | 4 payments
|
| Merck Sharp & Dohme | Dificid | $56 | 3 payments
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 85.8 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1710255591
- Licence
- CA A133960California A133960: Current · expires 2028-11-30Washington MD.MD.61519396: Active
- Trained
- University of California, Davis School of Medicine, 2013 · 13 years ago
- Group
- King County Public Hospital District No 2 · Community Foundation Medical Group
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RG0100X (207RG0100X)
- Mailing address
- 12333 Ne 130th Ln Ste 400, Kirkland, WA, 98034
- NPI first listed
- 2011-12-07
- NPI last updated
- 2025-02-07
- NPI record certified
- 2025-02-05
This is when the NPI record was last certified, not a medical board exam.